The EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.

Creators: Smolen JS; Landewé R; Breedveld FC; Buch M; Burmester G; Dougados M; Emery P; Gaujoux-Viala C; Gossec L; Nam J; Ramiro S; Winthrop K; de Wit M; Aletaha D; Betteridge N; Bijlsma JW; Boers M; Buttgereit F; Combe B; Cutolo M; Damjanov N; Hazes JM; Kouloumas M; Kvien TK; Mariette X; Pavelka K; van Riel PL; Rubbert-Roth A; Scholte-Voshaar M; Scott DL; Sokka-Isler T; Wong JB; van der Heijde D.

Others:: Smolen, J; Landewé, R; Breedveld, Fc; Buch, M; Burmester, G; Dougados, M; Emery, P; Gaujoux-Viala, C; Gossec, L; Nam, J; Ramiro, S; Winthrop, K; de Wit, M; Aletaha, D; Betteridge, N; Bijlsma, Jw; Boers, M; Buttgereit, F; Combe, B; Cutolo, M; Damjanov, N; Hazes, Jm; Kouloumas, M; Kvien, Tk; Mariette, X; Pavelka, K; van Riel, Pl; Rubbert-Roth, A; Scholte-Voshaar, M; Scott, Dl; Sokka-Isler, T; Wong, Jb; van der Heijde, D.

Additional details